Ascorbyl Palmitate

Dosage for Ascorbyl Palmitate varies significantly based on the intended use. For general antioxidant support and as a source of Vitamin C, the typical adult dosage ranges from 250 mg to 1,000 mg per day, usually divided into two doses to maintain steady plasma levels.

In the context of urinary acidification or as a Calculi Dissolution Agent, healthcare providers may recommend higher doses, sometimes up to 2,000 mg per day, though this requires close monitoring of urinary pH and renal function. When used as a Standardized Chemical Allergen for diagnostic purposes, a single application of a 1% concentration is typically applied to the skin under an occlusive patch for 48 hours.

The safety and efficacy of Ascorbyl Palmitate in pediatric populations have not been extensively established through large-scale clinical trials. For children, Vitamin C requirements are generally met through standard L-ascorbic acid. If a healthcare provider deems Ascorbyl Palmitate necessary, the dose is typically calculated based on the child's weight or age, often not exceeding 100 mg to 250 mg daily. Pediatric use for allergy testing is conducted only under the direct supervision of a pediatric allergist.

Renal Impairment

Patients with a history of kidney stones (especially calcium oxalate stones) or chronic kidney disease (CKD) must use Ascorbyl Palmitate with extreme caution. High doses of Vitamin C esters can increase urinary oxalate excretion. For patients with a GFR (Glomerular Filtration Rate) below 30 mL/min, dosage reduction or avoidance is typically recommended to prevent the formation of oxalosis (calcium oxalate deposits in tissues).

Hepatic Impairment

Since the liver is a primary site for the esterase-mediated hydrolysis of Ascorbyl Palmitate, patients with severe hepatic impairment (Child-Pugh Class C) may experience altered metabolism of the drug. While specific dose adjustments are not standardized, close monitoring of liver enzymes is advised during high-dose therapy.

Elderly Patients

No specific dosage adjustments are generally required for the elderly; however, clinicians should consider the higher prevalence of reduced renal function in this population. Starting at the lower end of the dosing range (250 mg) is often prudent.

• With Food: Ascorbyl Palmitate is fat-soluble and is best absorbed when taken with a meal containing some dietary fat (e.g., avocado, nuts, or olive oil).
• Timing: If taking multiple doses, space them evenly throughout the day (e.g., morning and evening).
• Swallowing: Capsules should be swallowed whole with a full glass of water. Do not crush or chew unless specifically instructed by a pharmacist.
• Storage: This compound is sensitive to light, heat, and air. Store in a cool, dry place in an amber-colored, airtight container to prevent oxidation and degradation.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this can increase the risk of gastrointestinal irritation.

Acute overdose of Ascorbyl Palmitate is rarely life-threatening but can cause significant distress. Signs of overdose include:

• Severe diarrhea and abdominal cramping
• Nausea and vomiting
• Flushed skin
• Headache

In the event of a massive ingestion, seek emergency medical attention or contact a poison control center immediately. Treatment is generally supportive, focusing on hydration and electrolyte balance.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance, especially if you have underlying health conditions like kidney disease or iron overload disorders.

Ascorbyl Palmitate is generally well-tolerated when used at recommended dosages. However, common side effects, particularly with oral ingestion, include:

• Gastrointestinal Distress: This may manifest as mild nausea, bloating, or 'sour stomach.' Because it is an acidifying agent, it can occasionally irritate the gastric lining.
• Diarrhea: High doses can have an osmotic effect in the gut, leading to loose stools. This typically resolves once the dosage is reduced.
• Abdominal Cramping: Often associated with the increased acidity in the digestive tract.

• Heartburn (GERD): Some patients may experience an exacerbation of acid reflux symptoms.
• Headache: Mild, transient headaches have been reported shortly after ingestion.
• Skin Flushing: A temporary feeling of warmth or redness, though this is more common with nicotinic acid, it can occur with high-dose Vitamin C derivatives.

• Hyperoxaluria: An excess of oxalate in the urine, which can lead to the formation of kidney stones in susceptible individuals.
• Hemolysis: In individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, high doses of Vitamin C esters can cause the premature destruction of red blood cells.
• Dental Erosion: If powder forms are consumed without proper rinsing, the acidic nature can theoretically affect tooth enamel over long periods.

> Warning: Stop taking Ascorbyl Palmitate and call your doctor immediately if you experience any of these.

• Anaphylaxis or Severe Allergic Reaction: Symptoms include swelling of the face, lips, or tongue; difficulty breathing; severe hives; or a rapid heart rate. As a 'Standardized Chemical Allergen,' this is a known risk for sensitized individuals.
• Severe Flank Pain: This may indicate the movement or formation of a kidney stone (renal calculi).
• Blood in the Urine (Hematuria): A potential sign of renal irritation or stone formation.
• Yellowing of the Eyes/Skin (Jaundice): While rare, this could indicate hepatic stress or hemolysis.

Prolonged use of high-dose Ascorbyl Palmitate (exceeding 2,000 mg/day) may lead to:

1. 1Kidney Stone Formation: Chronic acidification and increased oxalate levels significantly raise the risk of calcium oxalate stones.
2. 2Iron Overload: Vitamin C enhances the absorption of non-heme iron. In patients with conditions like hemochromatosis, this can lead to toxic iron accumulation in organs like the heart and liver.
3. 3Vitamin B12 Interference: There is some evidence that very high doses of Vitamin C can interfere with the absorption and metabolism of Vitamin B12, potentially leading to deficiency over years of use.

No FDA black box warnings currently exist for Ascorbyl Palmitate. It is generally considered a low-risk substance when used according to standard clinical guidelines. However, its classification as a standardized allergen means that its use in diagnostic testing must be performed by trained medical personnel to manage potential systemic allergic reactions.

Report any unusual symptoms to your healthcare provider. Monitoring of renal function and urinary oxalate may be necessary for those on long-term, high-dose therapy.

Ascorbyl Palmitate is a potent biochemical agent. While often perceived as a simple 'vitamin,' its fat-soluble nature and acidifying properties require careful clinical consideration. Patients should not assume that because it is a Vitamin C derivative, it can be taken in unlimited quantities. It is particularly important to distinguish between its use as a nutritional supplement and its role as a diagnostic allergen.

No FDA black box warnings for Ascorbyl Palmitate.

• Allergic Reactions / Anaphylaxis Risk: As a Standardized Chemical Allergen [EPC], Ascorbyl Palmitate is known to cause contact dermatitis. In rare cases, systemic exposure in highly sensitized individuals can lead to anaphylactoid reactions. Patients with known sensitivities to palmitates or ascorbic acid should avoid this compound.
• Nephrotoxicity and Calculi Risk: Due to its Acidifying Activity [MoA] and its metabolism into oxalate, there is a significant risk for patients predisposed to kidney stones. It should be used with caution in patients with a history of hyperoxaluria.
• Iron Overload Disorders: Patients with hemochromatosis, thalassemia, or sideroblastic anemia must avoid high doses of Ascorbyl Palmitate. The enhanced iron absorption caused by Vitamin C can lead to life-threatening iron toxicity in these populations.
• G6PD Deficiency: Individuals with a deficiency in the G6PD enzyme are at risk for hemolytic anemia when exposed to high doses of oxidative substances, including Vitamin C derivatives.

For patients prescribed Ascorbyl Palmitate for clinical reasons (such as calculi dissolution or high-dose antioxidant therapy), the following monitoring is recommended:

• Urinary Oxalate Levels: Periodic 24-hour urine collections to ensure oxalate levels remain within a safe range.
• Renal Function Tests: Monitoring of Serum Creatinine and GFR, especially in the elderly or those with pre-existing kidney disease.
• Complete Blood Count (CBC): To check for signs of hemolysis in at-risk groups.
• Serum Iron and Ferritin: To monitor for potential iron overload.

Ascorbyl Palmitate does not typically cause sedation or cognitive impairment. It is generally considered safe to drive or operate machinery while taking this supplement, provided no rare side effects like severe headache or dizziness occur.

There are no direct contraindications between Ascorbyl Palmitate and moderate alcohol consumption. However, alcohol can irritate the gastric mucosa, and when combined with the acidifying effect of Ascorbyl Palmitate, it may increase the risk of gastritis or heartburn.

Sudden discontinuation of very high doses of Vitamin C derivatives can occasionally lead to 'rebound scurvy.' This is a theoretical condition where the body, having become accustomed to high levels of the vitamin, continues to metabolize it at an accelerated rate even after the intake stops. It is advisable to taper off high doses (e.g., >1,000 mg) over the course of one to two weeks.

> Important: Discuss all your medical conditions, especially kidney problems or blood disorders, with your healthcare provider before starting Ascorbyl Palmitate.

• Deferoxamine (high dose): While Vitamin C is sometimes used with deferoxamine to improve iron chelation, taking high doses of Ascorbyl Palmitate simultaneously can increase iron toxicity, particularly in the heart, leading to potentially fatal cardiac failure. This combination must only be used under strict specialist supervision.

• Warfarin (Coumadin): High doses of Vitamin C derivatives have been reported to interfere with the anticoagulant effect of warfarin, potentially lowering the International Normalized Ratio (INR) and increasing the risk of blood clots. Patients on blood thinners require frequent INR monitoring when starting or stopping Ascorbyl Palmitate.
• Bortezomib (Velcade): Vitamin C can reduce the effectiveness of this chemotherapy agent used in multiple myeloma. Patients undergoing cancer treatment should consult their oncologist before taking any Vitamin C supplements.
• Estrogens/Oral Contraceptives: Vitamin C can increase the absorption and plasma levels of estrogens, potentially increasing the risk of side effects like blood clots.

• Aspirin: Aspirin can increase the excretion of Vitamin C, while Vitamin C can decrease the excretion of aspirin, potentially leading to higher aspirin levels in the blood.
• Aluminum-containing Antacids: Vitamin C can increase the absorption of aluminum, which may be harmful to patients with renal failure.
• Statins and Niacin: There is some evidence that antioxidant supplements (including Vitamin C and E) may blunt the rise in 'good' HDL cholesterol in patients taking the combination of simvastatin and niacin.

• High-Fat Meals: Since Ascorbyl Palmitate is fat-soluble, taking it with high-fat meals significantly increases its absorption. While this is generally beneficial for efficacy, it may increase the risk of side effects in sensitive individuals.
• Dairy: No significant interactions with dairy products have been established.

• Iron Supplements: Ascorbyl Palmitate significantly increases the absorption of non-heme iron (the type found in plants and supplements). This is beneficial for treating iron-deficiency anemia but dangerous for those with iron overload.
• Vitamin E: These two antioxidants work synergistically; Vitamin C helps regenerate oxidized Vitamin E, enhancing the overall antioxidant capacity.

Ascorbyl Palmitate can interfere with several common laboratory tests due to its chemical reducing properties:

• Urinary Glucose (Sugar) Tests: Can cause false-negative results in some glucose oxidase-based tests (e.g., Diastix).
• Fecal Occult Blood Tests (Guaiac-based): Can cause false-negative results, potentially masking the presence of blood in the stool.
• Serum Bilirubin and Creatinine: High levels may interfere with the chemical assays used to measure these markers.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Always inform laboratory staff that you are taking Ascorbyl Palmitate before undergoing blood or urine tests.

Ascorbyl Palmitate must NEVER be used in the following circumstances:

• Known Hypersensitivity: Any history of anaphylaxis or severe allergic reaction to Ascorbyl Palmitate, ascorbic acid, or palmitic acid. As a Standardized Chemical Allergen, the risk of a repeat reaction is high.
• Active Nephrolithiasis (Kidney Stones): Specifically, patients currently passing or being treated for calcium oxalate stones should avoid this acidifying agent, as it may exacerbate the condition.
• Severe G6PD Deficiency: Due to the risk of inducing hemolytic anemia (destruction of red blood cells).
• Hemochromatosis: Patients with this genetic condition of iron overload are at risk of organ damage if iron absorption is further enhanced by Vitamin C esters.

Conditions requiring careful risk-benefit analysis by a physician:

• Chronic Kidney Disease (CKD): The risk of secondary oxalosis (oxalate deposits) is high when renal clearance is impaired.
• History of Gastric Ulcers: The acidic nature of the compound may irritate the stomach lining, potentially worsening peptic ulcer disease.
• Thalassemia or Sideroblastic Anemia: These conditions involve iron handling issues that can be complicated by increased Vitamin C intake.
• Pregnancy (High Doses): While standard doses are safe, 'mega-doses' are not recommended due to a lack of safety data.

Patients who react to Ascorbyl Palmitate may also show cross-sensitivity to:

• Ascorbic Acid (Vitamin C): Though rare, some individuals are sensitive to the parent molecule.
• Palmitate Esters: Used in various cosmetics and topical medications (e.g., Retinyl Palmitate). Individuals with a 'Standardized Chemical Allergen' reaction to Ascorbyl Palmitate should be screened for sensitivity to other palmitic acid derivatives.

> Important: Your healthcare provider will evaluate your complete medical history, including any history of stones or blood disorders, before prescribing Ascorbyl Palmitate.

Ascorbyl Palmitate is generally considered safe during pregnancy when taken in amounts consistent with the Recommended Dietary Allowance (RDA). It is classified by many authorities as Pregnancy Category C (when used in high doses), meaning that while animal studies may show some risk or there are no controlled human studies, the benefits may outweigh the risks.

There is no evidence of teratogenicity (birth defects) at standard doses. However, very high doses (mega-dosing) should be avoided, as some studies suggest that the fetus may become 'conditioned' to high Vitamin C levels, potentially leading to withdrawal symptoms (scurvy) after birth. Always consult an obstetrician before starting any new supplement during pregnancy.

Ascorbic acid is a natural component of breast milk. Supplemental Ascorbyl Palmitate does pass into breast milk following the hydrolysis of the ester. At standard nutritional doses, it is considered safe for nursing infants. However, the effects of high-dose lipophilic Vitamin C esters on the composition of breast milk and the nursing infant have not been thoroughly studied. Monitoring the infant for gastrointestinal upset or rashes is advised if the mother is taking high doses.

Ascorbyl Palmitate is not the primary form of Vitamin C used in pediatric medicine. Most children meet their requirements through diet or water-soluble supplements. Its use as a Standardized Chemical Allergen in children is limited to specialized diagnostic cases for contact dermatitis. High-dose supplementation in children is generally discouraged unless specifically directed by a pediatrician, as it may interfere with bone development or renal function if oxalate levels become too high.

In elderly patients, the primary concern is the age-related decline in renal function (GFR). Since the metabolites of Ascorbyl Palmitate are excreted renally, there is an increased risk of oxalate accumulation. Additionally, elderly patients are more likely to be on polypharmacy (multiple medications), increasing the risk of drug interactions with anticoagulants like warfarin. Clinicians should emphasize hydration in this population to minimize the risk of stone formation.

For patients with a GFR < 60 mL/min, Ascorbyl Palmitate should be used with caution. If the GFR falls below 30 mL/min, high-dose therapy is typically contraindicated. Dialysis patients may require Vitamin C supplementation, but the fat-soluble Ascorbyl Palmitate is not the preferred form, as its clearance via dialysis is less predictable than water-soluble forms.

Patients with significant liver disease (e.g., cirrhosis) may have reduced levels of the esterase enzymes required to break down Ascorbyl Palmitate into its active components. While this does not usually lead to toxicity, it may reduce the efficacy of the supplement. No specific Child-Pugh based adjustments are published, but clinical monitoring is advised.

> Important: Special populations, particularly pregnant women and those with kidney disease, require individualized medical assessment before using Ascorbyl Palmitate.

Ascorbyl Palmitate acts primarily as a lipophilic antioxidant. Its molecular structure allows it to integrate into the lipid bilayer of cell membranes. Once positioned, it neutralizes reactive oxygen species (ROS) and free radicals that cause lipid peroxidation. This protects the integrity of the cell membrane and prevents damage to intracellular organelles.

As an Acidifying Activity [MoA] agent, it releases hydrogen ions upon metabolism, which can lower the pH of the urine. This change in the microenvironment is the basis for its use as a Calculi Dissolution Agent [EPC], as it increases the solubility of certain alkaline-dependent stones. Its Calcium Chelating Activity [MoA] further prevents the crystallization of calcium salts.

The pharmacodynamic effect of Ascorbyl Palmitate is characterized by a prolonged antioxidant presence in fatty tissues compared to ascorbic acid. The onset of its acidifying effect on urine typically occurs within 2-4 hours of oral ingestion and lasts for approximately 8-12 hours. Tolerance to the antioxidant effects does not typically develop, though the body may adapt to the acidifying effects over time through compensatory renal mechanisms.

| Parameter | Value |

|---|---|

| Bioavailability | ~40-60% (enhanced by dietary fat) |

| Protein Binding | Minimal for intact ester; Ascorbic acid ~25% |

| Half-life | 1.5 - 3 hours (intact ester) |

| Tmax | 2 - 4 hours |

| Metabolism | Hepatic and systemic esterases (Hydrolysis) |

| Excretion | Renal (as oxalate and ascorbic acid) |

• Molecular Formula: C22H38O7
• Molecular Weight: 414.5 g/mol
• Solubility: Soluble in alcohol and animal/vegetable oils; practically insoluble in water.
• Structure: An ester formed from the 6-carbon position of ascorbic acid and the carboxyl group of palmitic acid.

Ascorbyl Palmitate belongs to the therapeutic class of Vitamin C Derivatives and the diagnostic class of Standardized Chemical Allergens. It is related to other Vitamin C esters like Ascorbyl Stearate, though Palmitate is the most commonly used in clinical and industrial applications.